Skip to content

Bedside medical training therapy in the acute rehabilitation setting - a pilot study

Bedside medical training therapy in the acute rehabilitation setting - a pilot study - Bedside-MTT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032401
Enrollment
20
Registered
2023-07-28
Start date
2023-08-29
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immobility

Interventions

Group 1: Bedside MTT (medical training therapy) as add-on to acute (in-hospital) rehabilitation complex therapy Group 2: Acute (in-hospital) rehabilitation complex therapy

Sponsors

Charité Universitätsmedizin Berlin, Arbeitsbereich Physikalische Medizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Interdisciplinary early rehabilitation immobility (CHARMI < 5) sufficient understanding of speech basic physical ability for MTT available consent

Exclusion criteria

Exclusion criteria: Delir Exceeding the maximum dimensions for the use of the therapy system (foot/US too large for the foot shells, 200 cm, > 180 kg) Bone instability (partial load UEx postoperatively, osteoporosis, osteogenesis imperfecta) Acute inflammation (e.g. of the joints) Acute thrombosis Fresh neurological deficits Acute herniated disc Pre-damaged tendons (risk of rupture) ROM restriction UEx Severe contractures or fixed spasticity with hip and knee flexion or extension deficit > 30 °. Open body parts in contact with the device Expected incompliance (assessment of the study physician) Existing absolute or relative contraindications to bemo therapy Expected study drop out

Design outcomes

Primary

MeasureTime frame
The purpose of the study is to assess feasibility and safety as well as system usability on the part of patients and therapists. In addition, exploratory data on clinical outcomes will be used to generate endpoints for a subsequent confirmatory randomized controlled trial.

Secondary

MeasureTime frame
- Safety (MTT-associated complication rate) - Feasibility (user survey) - Usability from the perspective of the physiotherapist - Usability from patient's perspective - Mobility (CHARMI), duration to first independent mobility (days to CHARMI = 6) - ADL (Barthel index) - Hand strength - Muscle strength using knee extension - Length of stay in hospital and in early rehabilitation - Transfer/discharge environment - Sex - Age - BMI - Main diagnosis group, secondary diagnoses, procedures - Therapy units in early rehabilitation

Countries

Germany

Contacts

Public ContactAnett Reißhauer

Charité Universitätsmedizin Berlin, Arbeitsbereich Physikalische Medizin

anett.reisshauer@charite.de+49 30 450 517082

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026